Monitoring of biomarkers in heart failure

Research output: Contribution to journalArticlepeer-review

Abstract

The role of biomarkers is increasingly recognized in heart failure (HF) management, for diagnosis, prognostication, and screening of high-risk patients. Beyond natriuretic peptides and troponins, the utility of novel, emerging biomarkers is less established. This document reflects the key points of a Heart Failure Association of the European Society of Cardiology (ESC) consensus meeting on biomarker monitoring in HF.

Original languageEnglish
Pages (from-to)M5-M8
JournalEuropean Heart Journal, Supplement
Volume21
Issue numberSuppl M
DOIs
Publication statusPublished - Dec 2019

Fingerprint

Dive into the research topics of 'Monitoring of biomarkers in heart failure'. Together they form a unique fingerprint.

Cite this